Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
Stopped early · Phase 2
Conditions studied: Carcinoma, Non-Small Cell Lung
In brief
To assess the efficacy and safety of PF-3512676 administered in combination with pemetrexed for the treatment of patients with locally advanced or metastatic NSCLC who have failed one prior chemotherapy regimen
Key facts
- Study ID
- NCT00321308
- Run by
- Pfizer
- People needed
- 36
- Starts
- 2006-09-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2009-09-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Locally advanced or metastatic NSCLC
- Measurable disease
- ECOG PS 0 or 1
You may not qualify if…
- Known CNS metastasis
- Pre-existing autoimmune or antibody mediated disease
Where it is running
- Pfizer Investigational Site — Litchfield Park, Arizona, United States
- Pfizer Investigational Site — Sun City, Arizona, United States
- Pfizer Investigational Site — Bentonville, Arkansas, United States
- Pfizer Investigational Site — Fayetteville, Arkansas, United States
- Pfizer Investigational Site — Hudson, Florida, United States
- Pfizer Investigational Site — New Port Richey, Florida, United States
- Pfizer Investigational Site — Mahwah, New Jersey, United States
- Pfizer Investigational Site — Midland Park, New Jersey, United States
- Pfizer Investigational Site — Paramus, New Jersey, United States
- Pfizer Investigational Site — Westwood, New Jersey, United States
- Pfizer Investigational Site — Oneida, New York, United States
- Pfizer Investigational Site — Oswego, New York, United States
- Pfizer Investigational Site — Syracuse, New York, United States
- Pfizer Investigational Site — Syracuse, New York, United States
- Pfizer Investigational Site — Sylvania, Ohio, United States
- Pfizer Investigational Site — Seattle, Washington, United States
- Pfizer Investigational Site — Seattle, Washington, United States
- Pfizer Investigational Site — Großhansdorf, Germany
- Pfizer Investigational Site — Mannheim, Germany
- Pfizer Investigational Site — Torino, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.